Farid Takes Helm of Aurion MAB

Aurion Biotech names Marjan Farid chair of medical advisory board

Share

1

Marjan Farid has been appointed chair of Aurion Biotech's medical advisory board, focusing on vision restoration therapies.
2

Farid is a leading surgeon and clinical professor at the Gavin Herbert Eye Institute, UCI, specializing in cornea and cataract surgery.
3

Aurion is developing AURN001, an investigational cell therapy for corneal endothelial disease, currently in Phase 3 clinical trials.
4

In 2024, Aurion launched Vyznova, the first commercially available cell therapy for corneal endothelial disease.
5

Farid's expertise is expected to enhance Aurion's strategic direction and development of regenerative therapies for corneal disease.